trifarotene sold brand name aklief medication topical treatment acne specifically fourthgeneration selective retinoic acid receptor rarÎ³ trifarotene granted orphan drug designation treatment congenital ichthyosis us food drug administration fda european medicines agency approved medical use united states october december labelling package leaflet text received decentralised approval european united states trifarotene indicated topical treatment acne vulgaris people nine years age canada australia indicated topical treatment acne vulgaris face andor trunk people twelve years age trifarotene approved medical use united states october canada november australia january dermatologic drug article stub help wikipedia expanding httpsenwikipediaorgwikitrifarotene